Your browser doesn't support javascript.
loading
Neuronal intranuclear inclusion disease is genetically heterogeneous.
Chen, Zhongbo; Yan Yau, Wai; Jaunmuktane, Zane; Tucci, Arianna; Sivakumar, Prasanth; Gagliano Taliun, Sarah A; Turner, Chris; Efthymiou, Stephanie; Ibáñez, Kristina; Sullivan, Roisin; Bibi, Farah; Athanasiou-Fragkouli, Alkyoni; Bourinaris, Thomas; Zhang, David; Revesz, Tamas; Lashley, Tammaryn; DeTure, Michael; Dickson, Dennis W; Josephs, Keith A; Gelpi, Ellen; Kovacs, Gabor G; Halliday, Glenda; Rowe, Dominic B; Blair, Ian; Tienari, Pentti J; Suomalainen, Anu; Fox, Nick C; Wood, Nicholas W; Lees, Andrew J; Haltia, Matti J; Hardy, John; Ryten, Mina; Vandrovcova, Jana; Houlden, Henry.
Afiliação
  • Chen Z; Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London (UCL), London, UK.
  • Yan Yau W; Department of Neuromuscular Disease, Queen Square Institute of Neurology, UCL, London, UK.
  • Jaunmuktane Z; Department of Neuromuscular Disease, Queen Square Institute of Neurology, UCL, London, UK.
  • Tucci A; Queen Square Brain Bank, Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, UCL, UK.
  • Sivakumar P; Clinical Pharmacology, William Harvey Research Institute, School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Gagliano Taliun SA; Department of Neuromuscular Disease, Queen Square Institute of Neurology, UCL, London, UK.
  • Turner C; Center for Statistical Genetics and Department of Biostatistics, University of Michigan, Ann Arbor, Michigan.
  • Efthymiou S; Queen Square Institute of Neurology, UCL and the National Hospital for Neurology and Neurosurgery, Queen Square, London, UK.
  • Ibáñez K; Department of Neuromuscular Disease, Queen Square Institute of Neurology, UCL, London, UK.
  • Sullivan R; Clinical Pharmacology, William Harvey Research Institute, School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  • Bibi F; Department of Neuromuscular Disease, Queen Square Institute of Neurology, UCL, London, UK.
  • Athanasiou-Fragkouli A; University Institute of Biochemistry & Biotechnology, PMAS - Arid Agriculture University, Rawalpindi, Pakistan.
  • Bourinaris T; Department of Neuromuscular Disease, Queen Square Institute of Neurology, UCL, London, UK.
  • Zhang D; Department of Neuromuscular Disease, Queen Square Institute of Neurology, UCL, London, UK.
  • Revesz T; Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London (UCL), London, UK.
  • Lashley T; Queen Square Brain Bank, Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, UCL, UK.
  • DeTure M; Department of Neurodegenerative Disease, Queen Square Institute of Neurology, University College London (UCL), London, UK.
  • Dickson DW; Queen Square Brain Bank, Department of Clinical and Movement Neurosciences, Queen Square Institute of Neurology, UCL, UK.
  • Josephs KA; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida.
  • Gelpi E; Department of Neuroscience, Mayo Clinic, Jacksonville, Florida.
  • Kovacs GG; Mayo Clinic, Neurodegenerative Research Group, Rochester, Minnesota.
  • Halliday G; Neurological Tissue Bank of the Hospital Clinic-Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS) Biobank, Barcelona, Spain.
  • Rowe DB; Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Austria.
  • Blair I; Division of Neuropathology and Neurochemistry, Department of Neurology, Medical University of Vienna, Austria.
  • Tienari PJ; University of Toronto, Tanz Centre for Research in Neurodegenerative Disease, Toronto, Canada.
  • Suomalainen A; Neuroscience Research Australia, Sydney, Australia.
  • Fox NC; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, Australia.
  • Wood NW; Brain and Mind Centre, Sydney Medical School, The University of Sydney, Sydney, Australia.
  • Lees AJ; Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.
  • Haltia MJ; Centre for Motor Neuron Disease Research, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Macquarie University, Sydney, NSW, Australia.
  • Hardy J; Translational Immunology Research Program, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Ryten M; Research Programs Unit, Stem Cells and Metabolism, University of Helsinki, Helsinki, 00290, Finland.
  • Vandrovcova J; Neuroscience Center, HiLife, University of Helsinki, Helsinki, 00290, Finland.
  • Houlden H; HUSlab, Helsinki University Hospital, Helsinki, 00290, Finland.
Ann Clin Transl Neurol ; 7(9): 1716-1725, 2020 09.
Article em En | MEDLINE | ID: mdl-32777174
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas / Receptor Notch2 Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Neurodegenerativas / Receptor Notch2 Idioma: En Ano de publicação: 2020 Tipo de documento: Article